Back
Medacta Group SA Vs. NLS Pharmaceutics Industry Stock Comparison
Sell
33
MEDGF
Medacta Group SA
Last Price:
83.91
Seasonality Move:
1.73%
Sell
31
NLSP
NLS Pharmaceutics
Last Price:
1.94
Seasonality Move:
21.02%
Sell
33
Medacta Group SA (MEDGF)
is a Sell
Is Medacta Group SA a Buy, Sell or Hold?
- The current Medacta Group SA [MEDGF] share price is $83.91. The Score for MEDGF is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- MEDGF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
31
NLS Pharmaceutics (NLSP)
is a Sell
Is NLS Pharmaceutics a Buy, Sell or Hold?
- The current NLS Pharmaceutics [NLSP] share price is $1.91. The Score for NLSP is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- NLSP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MEDGF Stock Price Chart
What is Medacta Group SA's stock price today?
-
The Medacta Group SA share price today is $83.91
The current trend is relatively stagnant and MEDGF is experiencing slight buying pressure.
NLSP Stock Price Chart
What is NLS Pharmaceutics's stock price today?
-
The NLS Pharmaceutics share price today is $1.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NLSP is experiencing selling pressure, which indicates risk of future bearish movement.
MEDGF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Sell |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.91 - 83.91) | Sell |
Bollinger Bands (100): | (83.91 - 83.91) | Sell |
NLSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 23.76 | Sell |
Chaikin Money Flow: | -61833 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.33 - 3.67) | Sell |
Bollinger Bands (100): | (3.34 - 6.94) | Sell |
MEDGF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 83.91 | Sell |
20-day SMA: | 83.91 | Sell |
50-day SMA: | 83.91 | Sell |
200-day SMA: | 83.91 | Sell |
8-day EMA: | 83.91 | Sell |
20-day EMA: | 83.91 | Sell |
50-day EMA: | 83.91 | Sell |
200-day EMA: | 83.95 | Sell |
NLSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.13 | Sell |
20-day SMA: | 2.81 | Sell |
50-day SMA: | 3.75 | Sell |
200-day SMA: | 6.26 | Sell |
8-day EMA: | 2.18 | Sell |
20-day EMA: | 2.72 | Sell |
50-day EMA: | 3.64 | Sell |
200-day EMA: | 8.38 | Sell |
Medacta Group SA Earnings Growth & MEDGF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NLS Pharmaceutics Earnings Growth & NLSP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Medacta Group SA Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NLS Pharmaceutics Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |